46C-38349-61060
4 vaccinations
8 coded responses
50 check-ins
8 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 334 / FL
- Registered
- 2021-06-23
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-06-23
Registered in v-safe
-
2021-06-23
Dose 1 — Pfizer-BioNTech
- 2021-06-23
- 2021-06-24
- 2021-06-25
- 2021-06-26
- 2021-06-27
- 2021-06-28
- 2021-06-29
- 2021-06-30
- 2021-07-07
-
2021-07-14
Dose 2 — Pfizer-BioNTech
- 2021-07-14
-
2021-07-15
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-07-16
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-07-17
Survey response — days 1–6 daily, dose 2MedDRA: Hyperhidrosis — Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessFree text: SweatMedDRA releases: 2024-11 · check-in free text available
- 2021-07-18
-
2021-07-19
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-07-20
-
2021-07-21
Survey response — day 7, dose 2MedDRA: Blood glucose increased — Feeling: GoodFree text: Elevated blood sugarMedDRA releases: 2024-11 · check-in free text available
- 2021-07-28
- 2021-08-04
- 2021-08-11
- 2021-08-18
- 2021-08-25
- 2021-10-13
-
2022-01-10
Dose 3 — Pfizer-BioNTech
-
2022-01-10
Health check-in — day 0, dose 3Feeling: Fair · Site: Pain, Redness · Headache, Fatigue or tirednessAdult check-in
-
2022-01-11
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Poor · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Swollen lymph nodes under armpitMedDRA releases: 2024-11 · check-in free text available
-
2022-01-12
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain · Muscle or body aches · Be unable to do your normal daily activitiesFree text: Swollen glands under armMedDRA releases: 2024-11 · check-in free text available
-
2022-01-13
Survey response — days 1–6 daily, dose 3MedDRA: Oedema peripheral — Feeling: Good · Fatigue or tirednessFree text: Swollen underneath armMedDRA releases: 2024-11 · check-in free text available
- 2022-01-14
- 2022-01-15
-
2022-01-16
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Fatigue or tiredness, Diarrhea, Abdominal painAdult check-in
- 2022-01-17
- 2022-01-24
- 2022-01-31
- 2022-02-07
- 2022-02-14
- 2022-02-21
- 2022-04-11
-
2022-07-11
Survey response — 6 months, dose 3MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: CovidMedDRA releases: 2024-11 · check-in free text available
-
2022-09-12
Dose 4 — Pfizer-BioNTech
-
2022-09-12
Survey response — day 0, dose 4MedDRA: Hyperhidrosis — Feeling: Good · Site: PainFree text: SweatingMedDRA releases: 2024-11 · check-in free text available
-
2022-09-16
Health check-in — days 1–6 daily, dose 4Feeling: Good · Diarrhea, Rash, not including the immediate area around the injection siteAdult check-in
- 2022-09-17
- 2022-09-18
- 2022-09-19
- 2022-09-26
-
2022-10-03
Survey response — day 21, dose 4MedDRA: Influenza — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: FluMedDRA releases: 2024-11 · check-in free text available
-
2022-10-03
Report sent to call center — day 21, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-10-05
Call successfulDoes not wish to fill out VAERS report
- 2022-10-10
- 2022-10-19
- 2022-10-24
- 2022-12-12
- 2023-03-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-06-23 | Pfizer-BioNTech | No |
| 2 | 2021-07-14 | Pfizer-BioNTech | No |
| 3 | 2022-01-10 | Pfizer-BioNTech | No |
| 4 | 2022-09-12 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-10-03 | Successful 2022-10-05 |
Does not wish to fill out VAERS report |
Free text
Release 9 — days 1–6 daily, dose 2
Systemic reaction (other): Sweat
Release 9 — day 7, dose 2
Systemic reaction (other): Elevated blood sugar
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Swollen lymph nodes under armpit
Systemic reaction (other): Swollen glands under arm
Systemic reaction (other): Swollen underneath arm
Release 12 — 6 months, dose 3
Symptoms: Covid
Release 12 — day 0, dose 4
Systemic reaction (other): Sweating
Release 12 — day 21, dose 4
Symptoms: Flu
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Influenza | · | · | ✓ |
| SRO | Blood glucose increased | · | · | ✓ |
| SRO | Hyperhidrosis | · | · | ✓ |
| SRO | Lymphadenopathy | · | · | ✓ |
| SRO | Oedema peripheral | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release